Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox’s Denali Phase 3 Trial of NCX 470 Fully Enrolled in China Earlier than Expected

December 2, 2024

View Press Release Corporate presentation Contact us
Previous